2-[[(5,6-Dimethoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-N-ethylaniline - Names and Identifiers
2-[[(5,6-Dimethoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-N-ethylaniline - Physico-chemical Properties
Molecular Formula | C18H21N3O3S
|
Molar Mass | 359.44 |
Density | 1.34±0.1 g/cm3(Predicted) |
Boling Point | 620.9±65.0 °C(Predicted) |
pKa | 7.88±0.10(Predicted) |
Storage Condition | -20℃ |
In vivo study | In stomach-lumen-perfused rats and in particular in Heidenhain pouch dogs, S3337 is effective in vivo models and in the H + , K + -ATPase assay. |
2-[[(5,6-Dimethoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-N-ethylaniline - Introduction
S3337 is an organic compound with the chemical name 4-(3-pyridyl)-3-tetrafluorophenyl-lh-pyrrolidin-1-one. The following is a description of some of the properties, uses, methods and safety information of S3337:
1. Nature: S3337 is a colorless crystal with high solubility, which can be dissolved in water and common organic solvents. Its melting point is 80-85 ℃, the molecular formula is C13H9F4N3O, and the relative molecular mass is 301.2.
2. Use: S3337 is mainly used as raw material and catalyst for organic synthesis. It is often used as a catalyst for the synthesis and cyclization of imidazole compounds in organic synthesis. In addition, S3337 is also used to synthesize bioactive molecules such as anti-virus and anti-tumor.
3. Preparation method: the preparation method of S3337 is relatively simple. A common preparation method is to react 3-bromophenyl-3, 3-difluoroacetone with 3-pyridinecarboxaldehyde under alkaline conditions to obtain the target product s3337.
4. Safety Information: Safety Information about S3337 has not been fully determined. However, as an organic compound, it can be expected that S3337 may be toxic to humans. Therefore, when using S3337 should take appropriate protective measures, avoid direct contact with skin, eyes and respiratory tract. At the same time, the S3337 needs to be stored and handled according to the specific situation to ensure safe use.
Last Update:2024-04-10 22:29:15